Integrity are hosting a series of live events in Europe and the US, with the first one being held in Ireland on 17th Nov.

Join them and their guest speakers to find out how the industry is tackling the challenges of developing quality products from manufacturing through clinical applications, commercialization, regulatory issues, to right sized automation and quality solutions.

You will hear from those who have already achieved lift-off and succeeded commercially, experts from the C-suite, commercial strategy, manufacturing and supply.

Everyone who attends will receive an exclusive report.

Book your seat today!

Case studies to be featured

  • Tackling the challenges of the C&GT Journey
  • Managing Manufacturing & Supply Chain Scalability & Traceability
  • Right Sizing IT Solutions and Validation

Ireland Guest Speakers 2022

Chris Reid

Chris is the CEO and founder of Integrity. He has worked in the life science industry for over 30 years alongside many leading global organisations, overseeing the delivery of quality and compliance solutions. Chris has experience across a variety of organisations and disciplines including IS/IT, Engineering, Business, QA and Suppliers. Chris is a member of the ISPE GAMP Global Steering Committee through which he helps to establish pragmatic, risk-based quality and compliance guidance. He is also a member of the ISPE Foundation Board Executive team.

Stan O’Neill

Stan O’Neill is the MD of The Compliance Group and Technical Director of Compliance Management, both of which consult for the pharmaceutical industry, NGOs and Governments. Originally qualifying as a pharmacist, he worked in a production facility before joining the Irish Medicines Board, (now the HPRA). As a Senior Inspector, he represented Ireland at the EMA GMDPIW G and the PIC/S Expert Circle on Computerised Systems, resulting in him acting as Rapporteur for Annex 11. He holds Honorary Associate Professorships in Trinity College Dublin and RCSI.

Gary McAuslan

Chief Executive Officer and Co-Founder of Biotech and Cell & Gene Therapy Businesses GMACPHARMA and aCGT Vector Specialising on the Commercialising of Precision Medicines. Adjunct Professor of The School of Pharmacy University of Dublin, Trinity College Dublin Teaching the Modern Complexities of the Cell & Gene Therapy Sector and Personalised Precision Medicines.

Frank Barry

Frank Barry is Professor of Cellular Therapy at the Regenerative Medicine Institute (REMEDI) University of Galway. He is the Co-Director of the Centre of Cell Manufacturing Ireland (CCMI). He is Principle Investigator on the CALIN Project, Coordinator of the ADIPOA2 Clinical trial and Senior Investigator in the AUTOcrat, RESPINE and and StarStem projects.

Greg Simmonds

Greg Simmonds is Head of Manufacturing for MeiraGTx, a vertically integrated gene therapy discovery, development and manufacturing business with locations in USA, UK, Netherlands and Ireland. Greg moved recently to drive operational readiness and startup for the MeiraGTx Ireland facility in Shannon, Co. Clare having led UK Manufacturing for the previous two years. Prior to MeiraGTx, Greg spent 13 years with GSK in a variety of positions and is also a Chartered Chemical Engineer.

Jack McCarthy

Jack started his career at GSK, joining as one of the first on the Supply Chain Degree Apprenticeship scheme in 2014. W hilst at GSK, Jack worked in roles of increasing responsibility, both at manufacturing sites and at Head Office, in Supply Chain, Global Planning, Quality and Manufacturing. Jack joined MeiraGTx in March 2021 as the UK Supply Chain Lead and helped lead the Supply Chain organisation through a challenging period where the pandemic significantly disrupted global supply chains. Since then, Jack also assumed responsibility for External Supply & CMC.